In vitro antitumor and immunomodulatory activities of 1,2,4-oxadiazole derivatives

Héverton Mendes Araújo1, Gabriel Acácio de Moura1,2, Yasmim Mendes Rocha1,2

  • 1Post-Graduate Program in Pharmaceutical Sciences (PPGCF), Federal University of Ceará (UFC), Fortaleza, CE, Brazil.

Insights

This study shows that 1,2,4-oxadiazole derivative 2 has antitumor effects against melanoma cells and can repolarize tumor-associated macrophages (TAMs) to an M1 phenotype, enhancing immune response.

Area of Science:

  • Immunology
  • Oncology
  • Medicinal Chemistry

Background:

  • Melanoma, a lethal skin cancer, often requires combination therapy for advanced cases.
  • Tumor-associated macrophages (TAMs) are key players in tumor immunity, with M1 polarization showing anti-tumor effects.
  • 1,2,4-oxadiazole derivatives show promise as therapeutic agents due to their antitumor and immunomodulatory activities.

Purpose of the Study:

  • To evaluate the antitumor and immunomodulatory effects of the synthetic 1,2,4-oxadiazole derivative 2.
  • To assess the compound's impact on melanoma cells and murine Bone Marrow-Derived Macrophages (BMDMs).

Main Methods:

  • Cytotoxicity was assessed using the MTT assay on B16-F10 melanoma cells and BMDMs.
  • Macrophage polarization to M1 phenotype and cytokine production (TNF-α, nitrite, IL-12) were analyzed.
  • Synergistic effects were investigated by combining the derivative with melanoma supernatants and LPS.

Main Results:

  • 1,2,4-oxadiazole derivative 2 demonstrated antiproliferative effects on B16-F10 cells and BMDMs, with higher selectivity for melanoma cells.
  • The compound induced necrosis in cancer cells and promoted M1 polarization in BMDMs, increasing TNF-α production.
  • Combinations of the derivative with melanoma supernatants or LPS showed synergistic effects on M1 polarization and TNF-α production.

Conclusions:

  • 1,2,4-oxadiazole derivative 2 exhibits significant antitumor and immunomodulatory potential.
  • The compound effectively repolarizes macrophages to an anti-tumor M1 phenotype.
  • This derivative represents a promising candidate for novel antitumoral and immunotherapeutic strategies against melanoma.

Related Concept Videos